Arthur M. Cohen & Associates, LLC / LLY
Arthur M. Cohen & Associates, LLC’s Eli Lilly & Co Position
Does Arthur M. Cohen & Associates, LLC own Eli Lilly & Co (LLY)? Yes — 22.2K shares worth $21M (+3.76% of its 13F portfolio) as of Q1 2026, down from 22.5K shares the prior filed quarter.
Position Value
$21M
Q1 2026
Shares
22.2K
% of Portfolio
+3.76%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 22.2K | $21M | +3.76% |
| Q4 2025 | 22.5K | $24M | +3.95% |
| Q3 2025 | 22.8K | $17M | +2.93% |
| Q2 2025 | 22.7K | $18M | +3.13% |
| Q1 2025 | 23.6K | $19M | +3.74% |
| Q4 2024 | 24.2K | $19M | +3.31% |
| Q3 2024 | 25.5K | $23M | +4.07% |
| Q2 2024 | 25.8K | $23M | +4.28% |
| Q1 2024 | 26.0K | $20M | +4.29% |
| Q4 2023 | 26.9K | $16M | +3.68% |
| Q3 2023 | 29.2K | $16M | +4.01% |
| Q2 2023 | 30.2K | $14M | +3.52% |
| Q1 2023 | 31.2K | $11M | +2.87% |
| Q4 2022 | 33.5K | $12M | +3.35% |
| Q3 2022 | 37.8K | $12M | +3.36% |
| Q2 2022 | 39.3K | $13M | +3.21% |
| Q1 2022 | 40.0K | $11M | +2.42% |
| Q4 2021 | 45.5K | $13M | +2.33% |
| Q3 2021 | 46.8K | $11M | +2.19% |
| Q2 2021 | 47.0K | $11M | +2.09% |
| Q1 2021 | 26.6K | $9M | +2.02% |
| Q4 2020 | 46.7K | $8M | +1.85% |
| Q3 2020 | 46.7K | $7M | +1.79% |
| Q2 2020 | 46.0K | $8M | +2.38% |
| Q1 2020 | 46.0K | $6M | +2.49% |
| Q4 2019 | 46.4K | $6M | +1.87% |
| Q3 2019 | 48.2K | $5M | +1.52% |
| Q2 2019 | 46.9K | $5M | +1.80% |
| Q1 2019 | 49.0K | $6M | +2.27% |
| Q4 2018 | 49.4K | $6M | +1.82% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Arthur M. Cohen & Associates, LLC’s full portfolio or all institutional holders of LLY.